Phosphate supplementation in parenteral nutrition.

Area of Science:

• Clinical Nutrition
• Critical Care Medicine
• Mineral Metabolism

Background:

• Phosphate deficiency is detrimental in malnourished patients on parenteral nutrition.
• The phosphate requirements for critically ill patients are not well-established.
• Standard parenteral nutrition may not provide adequate phosphate.

Purpose of the Study:

• To investigate the consequences of phosphate deficiency in critically ill patients.
• To determine the optimal phosphate supplementation for intensive care unit (ICU) patients receiving parenteral nutrition.
• To assess the safety and efficacy of high-dose phosphate administration.

Main Methods:

• Randomized controlled trial involving 30 ICU patients.
• Comparison of parenteral nutrition with standard (low phosphate) versus supplemented (high phosphate) formulations.
• Measurement of serum phosphate, calcium levels, and mineral balance.

Main Results:

• High phosphate group (60-80 mmol/day) achieved positive phosphate balance and zero calcium balance.
• Low phosphate group (7.5 mmol/day) exhibited negative phosphate and calcium balances.
• No significant differences in serum phosphate or calcium levels between groups.
• Patients tolerated up to 80 mmol of phosphate per day.

Conclusions:

• Standard parenteral nutrition phosphate content is insufficient for ICU patients.
• Intensive care unit patients may require and tolerate up to 80 mmol of phosphate daily.
• Establishing precise phosphate administration guidelines for ICU patients remains challenging.